- Home
- NAMS vs FOUR Comparison
NAMS vs FOUR Comparison
Compare NAMS & FOUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NAMS | FOUR |
|---|---|---|
| Founded | 2019 | 1999 |
| Country | Netherlands | United States |
| Employees | 100 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.0B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | NAMS | FOUR |
|---|---|---|
| Price | $32.43 | $48.21 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 22 |
| Target Price | $46.75 | ★ $82.35 |
| AVG Volume (30 Days) | 761.2K | ★ 1.8M |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $4,180,000,000.00 |
| Revenue This Year | $17.96 | $23.83 |
| Revenue Next Year | $540.65 | $14.30 |
| P/E Ratio | ★ N/A | $27.53 |
| Revenue Growth | N/A | ★ 25.50 |
| 52 Week Low | $16.79 | $39.91 |
| 52 Week High | $42.00 | $107.16 |
Technical Indicators
Market Signals| Indicator | NAMS | FOUR |
|---|---|---|
| Relative Strength Index (RSI) | 47.71 | 54.18 |
| Support Level | $29.73 | $40.25 |
| Resistance Level | $37.25 | $55.46 |
| Average True Range (ATR) | 1.68 | 2.12 |
| MACD | -0.04 | 0.98 |
| Stochastic Oscillator | 17.31 | 76.65 |
Price Performance
Historical ComparisonAbout NAMS NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments. The Company has one reportable segment, which comprises the discovery, development, and commercialization of transformative therapies for cardio-metabolic diseases.
About FOUR Shift4 Payments Inc.
Shift4 Payments Inc is provider of integrated payment processing and technology solutions. The company offers software providers a single integration to an end-to-end payments offering, a powerful gateway and a robust suite of technology solutions (including cloud enablement, business intelligence, analytics, and mobile) to enhance the value of their software suites and simplify payment acceptance. The company derives maximum revenue from United States.